Hideshima, Teru
Harvard Medical School,
United States
2025 Rank: 98477
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1814 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98477 | 112873 |
| Total Cites | 1270 | 1325 |
| H-index | 15 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 212 | 216 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 212 | 216 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 959 | 988 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.34 |
| Self-Citation Percentage |
4.15%
|
|
Hideshima, Teru
Dana-Farber Cancer Institute,
United States
2024 Rank: 92734
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1819 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92734 | 98719 |
| Total Cites | 1305 | 1384 |
| H-index | 14 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 192 | 197 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 193 | 198 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 996 | 1019 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.36 |
| Self-Citation Percentage |
5.71%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2023 Rank: 63437
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1416 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63437 | 70008 |
| Total Cites | 1558 | 1638 |
| H-index | 16 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 262 | 267 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 263 | 268 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1119 | 1157 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.42 |
| Self-Citation Percentage |
4.88%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2022 Rank: 50805
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1272 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50805 | 52148 |
| Total Cites | 1792 | 1949 |
| H-index | 18 | 19 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 279 | 310 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 282 | 313 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1272 | 1318 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.48 |
| Self-Citation Percentage |
8.06%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2021 Rank: 50572
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1173 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50572 | 54710 |
| Total Cites | 2683 | 2892 |
| H-index | 24 | 25 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 430 | 469 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 433 | 472 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1885 | 1966 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.47 |
| Self-Citation Percentage |
7.23%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2020 Rank: 43524
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 957 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43524 | 47756 |
| Total Cites | 2074 | 2220 |
| H-index | 20 | 20 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 365 | 383 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 365 | 383 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1450 | 1516 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.46 |
| Self-Citation Percentage |
6.58%
|
|